| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 05/14/1999 | CA2307380A1 Process for the production of highly viral safe components for forming fibrin glue from a pool of human plasma |
| 05/14/1999 | CA2221195A1 Biodegradable polymer matrix |
| 05/12/1999 | EP0915167A1 In vivo method of obtaining cell components |
| 05/12/1999 | EP0915165A1 Method for the helper virus-free packaging of a DNA-vector |
| 05/12/1999 | EP0914778A1 Oral administration of bacteria at a concentration which produces cell-mediated immunity and weight in certain animals |
| 05/12/1999 | EP0914607A2 Method for the identification and therapeutic use of disease-associated organisms, elements and forces |
| 05/12/1999 | EP0914459A2 Adenoviral mediated gene transfer in adipocytes and related implants |
| 05/12/1999 | EP0914456A1 Gene expression in monocytes and macrophages |
| 05/12/1999 | EP0914444A1 Vectors comprising sar elements |
| 05/12/1999 | EP0914434A2 Method for preparing transgenic non-human mammalian organs for transplantation to humans, and nucleotide sequences therefor |
| 05/12/1999 | EP0914426A1 Sequences ahead of gene sm22, vectors containing same, and therapeutical uses thereof, particularly for treating vascular diseases |
| 05/12/1999 | EP0914418A1 Method for producing therapeutic dna |
| 05/12/1999 | EP0914416A1 Method for the production of activated marked tumor-specific t cells and use thereof in treatment of tumors |
| 05/12/1999 | EP0914414A1 Laminin 5 for growth of pancreatic islet cells |
| 05/12/1999 | EP0914339A2 RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH |
| 05/12/1999 | EP0914202A1 Preservation by foam formation |
| 05/12/1999 | EP0914166A1 Methods of terminal sterilization of biological products |
| 05/12/1999 | EP0914163A1 Novel processes implementing selective immune down regulation (sidr) |
| 05/12/1999 | EP0914114A1 Methods of treating type i hypersensitivity using monophosphoryl lipid a |
| 05/12/1999 | EP0914107A1 Compositions comprising lidocaine and emu oil and methods of use thereof |
| 05/12/1999 | EP0914043A1 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof |
| 05/12/1999 | EP0751940B1 Sesquiterpenic derivatives |
| 05/12/1999 | EP0705114B1 Process and apparatus for removal of unwanted fluids from processed blood products |
| 05/12/1999 | CN1216255A Preparation of ethanol extracted earthworm tissue liquid |
| 05/12/1999 | CN1216253A Cancer curing medicine liquid |
| 05/12/1999 | CN1216247A Plaster for drawing out pus and promoting tissue regeneration and its preparation |
| 05/12/1999 | CN1043308C Drug for external use for treating necrosis of femoral head |
| 05/12/1999 | CN1043307C Drug for external use for treating necrosis of femoral head |
| 05/12/1999 | CN1043306C Quick-acting hemostatic powder |
| 05/12/1999 | CN1043302C Medicine with function of relieving cough and reducing sputum |
| 05/11/1999 | US5902743 Probiotic bifidobacterium strain |
| 05/11/1999 | US5902741 Inoculating stromal cells onto biocompatible, nonliving frame in nutrient media, cells attach, proliferate and differentiate forming structure; for transplants, drug screening, gene therapy |
| 05/11/1999 | US5902627 Process for the production of alkali-treated yogurt powder possessing an immunological activity |
| 05/11/1999 | US5902608 Platelets adhered to a solid substrate that upon reconstitution adhere and spread and form a hemostatic plug to thrombogenic surfaces; do not adhere to non-thrombogenic surfaces, and release platelet-derived growth factor |
| 05/11/1999 | US5902585 Methods of inducing T cell unresponsiveness to donor tissue or organ in a recipient with GP39 antagonists |
| 05/11/1999 | US5902583 Genetic induction of receptors for targeted radiotherapy |
| 05/11/1999 | US5902578 Mixing powder containing viable lactobacillus reuteri, lactobacillus acidophilus and bifidobacterium infantis with a liquid and enterally administering effective dosage to human prior to the formation of fermentation by-products |
| 05/11/1999 | US5902577 Insulin-secreting cell lines, methods of production and use |
| 05/11/1999 | CA2141871C Novel attenuated pseudomonas aeruginosa strains |
| 05/11/1999 | CA2046632C Thrombolytic from vampire bat saliva |
| 05/07/1999 | CA2253064A1 Nef action inhibitor |
| 05/06/1999 | WO1999021968A1 INDUCIBLE CELLULAR IMMUNITY THROUGH ACTIVATION OF Th1 AND SUPPRESSION OF Th2 RESPONSES BY MACROPHAGES |
| 05/06/1999 | WO1999021966A1 Erythropoietin-mediated neurogenesis |
| 05/06/1999 | WO1999021434A1 Composition containing useful substances originating in fishes and shellfishes and process for the preparation of the substances |
| 05/06/1999 | WO1999015683A8 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site |
| 05/06/1999 | WO1999013054A3 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues |
| 05/06/1999 | WO1999010516A3 Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta |
| 05/06/1999 | WO1998054301B1 Transplants for myocardial scars and method and cellular preparations therefor |
| 05/06/1999 | EP0913481A2 Staphylococcus aureus member of the DEAD-type ATP-dependent RNA helicases (dbpB) |
| 05/06/1999 | EP0913477A2 LacC gene encoding a tagatose-6-phosphate kinase |
| 05/06/1999 | EP0912747A1 Aspartic protease |
| 05/06/1999 | EP0912188A1 Selective adsorbent for binding retroviruses |
| 05/06/1999 | EP0742721B1 Methods of prolonged suppression of humoral immunity |
| 05/06/1999 | CA2307600A1 Compositions containing useful substances derived from fishes and shellfishes, and process for yielding the useful substances |
| 05/06/1999 | CA2307017A1 Erythropoietin-mediated neurogenesis |
| 05/05/1999 | CN1215996A Indications for use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses |
| 05/05/1999 | CN1215611A Medicine for treatment of ischemic necrosis of fermoral head |
| 05/05/1999 | CN1215605A 'Shilongqingxue' Instant particle for treating hematencephalon |
| 05/05/1999 | CN1215594A Method for culture of stone of dog's gallbladder |
| 05/05/1999 | CN1215593A High active calcium tablet and producing process thereof |
| 05/05/1999 | CN1043188C Calcium protein oral liquid and its preparation process |
| 05/05/1999 | CN1043187C Evening cream for whitening and eliminating acne |
| 05/04/1999 | US5900377 Method for isolating and radiolabeling leukocytes for use in vivo |
| 05/04/1999 | US5899874 Method for recovering a platelet concentrate from blood |
| 05/04/1999 | CA2074641C Method of treating ocular inflammation |
| 04/30/1999 | CA2249056A1 Lacc |
| 04/29/1999 | WO1999021005A2 Pharmaceutical grade st. john's wort |
| 04/29/1999 | WO1999020774A2 NOVEL MODIFIED MSP-1 NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS |
| 04/29/1999 | WO1999020766A2 NOVEL MODIFIED NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS |
| 04/29/1999 | WO1999020745A1 Enteric coated microgranules for stabilizing lactic acid bacteria |
| 04/29/1999 | WO1999020739A2 Novel lactic acid bacteria species |
| 04/29/1999 | WO1999020288A1 Precipitation of growth-factor-enriched fibrinogen concentrate from platelet rich plasma |
| 04/29/1999 | WO1999020121A2 Methods for obtaining protein mixtures and control factors from wound granulation, epithelialization or determined blastocyst tissue |
| 04/29/1999 | WO1999011220A8 Transplants coated with autologous endothelial cells |
| 04/29/1999 | WO1999007332A3 A natural eubiotic product for maintenance and treatment of teguments |
| 04/29/1999 | WO1998058669A3 Cd154 blockade therapy for pancreatic islet tissue transplantation |
| 04/29/1999 | WO1998048027A9 Materials and methods for treatment of retinal diseases |
| 04/29/1999 | DE19756864C1 Production of neuronal or glial progenitor cells |
| 04/29/1999 | CA2306818A1 Pharmaceutical grade st. john's wort |
| 04/29/1999 | CA2306799A1 Novel modified nucleic acid sequences and methods for increasing mrna levels and protein expression in cell systems |
| 04/29/1999 | CA2306796A1 Novel modified msp-1 nucleic acid sequences and methods for increasing mrna levels and protein expression in cell systems |
| 04/29/1999 | CA2306629A1 Precipitation of growth-factor-enriched fibrinogen concentrate from platelet rich plasma |
| 04/29/1999 | CA2305891A1 New species of lactic acid bacterium |
| 04/28/1999 | EP0911410A2 Era polynucleotides and polypeptides from Streptococcus pneumoniae belonging to the GTPase family |
| 04/28/1999 | EP0911402A2 PyrR homolog from Staphylococcus aureus |
| 04/28/1999 | EP0911388A2 Method for stimulation of T-cells with desired antigenspecificity |
| 04/28/1999 | EP0910654A1 Enzyme combinations for destroying proliferative cells |
| 04/28/1999 | EP0910646A1 Brain glycogen phosphorylase cancer antigen |
| 04/28/1999 | EP0910641A1 Neural cell adhesion molecule splicing variants |
| 04/28/1999 | EP0910638A2 Polynucleotide encoding secreted proteins |
| 04/28/1999 | EP0910624A1 Process for producing and multiplying lymphocytes |
| 04/28/1999 | EP0910571A2 Novel antiangiogenic peptides, polypeptides encoding same and methods for inhibiting angiogenesis |
| 04/28/1999 | EP0910451A1 Multiple element filter |
| 04/28/1999 | EP0910409A1 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens |
| 04/28/1999 | EP0910395A1 Pharmaceutical composition which is stable during storage and contains a thymus extract |
| 04/28/1999 | EP0910394A1 Method for providing pathogen-free porcine tissue suitable for human transplantation |
| 04/28/1999 | EP0910393A1 Agent for the topical treatment of skin conditions |
| 04/28/1999 | EP0910387A1 Apoptosis associated protein bbk |
| 04/28/1999 | EP0910253A1 Peri-operative drink |
| 04/28/1999 | EP0859552A4 Liquid colostrum for dairy products |